Katherine I. Morley
Education
Ph.D. in population health, The University of Queensland, Australia; Grad. Cert. in health economics, The University of Queensland, Australia; B.Sc.(Hons) in genetics, The University of Queensland, Australia; B.A. in history, The University of Queensland, Australia
Overview
Kate Morley is a research leader with RAND Europe, where she works in public health and healthcare research. Before joining RAND Europe, she was a senior lecturer at the National Addiction Centre at the Institute of Psychiatry, Psychology and Neuroscience. She retains a visiting appointment there. Prior to joining the NAC she worked at the Centre for Molecular, Environmental, Genetic and Analytic Epidemiology at the University of Melbourne, the Department of Human Genetics at the Wellcome Trust Sanger Institute, and the Department of Epidemiology at University College London.
Morley works on a range of topics related to substance use and psychiatric epidemiology, but she is mainly focused on prognosis research, particularly using linked electronic record data.
Research Focus
Concurrent Non-RAND Positions
Visiting Senior Lecturer, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; Honorary Research Fellow, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of MelbourneSelected Publications
Kalk NJ, Kelleher MJ, Curtis V, Morley KI, "Addressing substance misuse: a missed opportunity in suicide prevention," Addiction, 114(3), 2019
Morley KI, Ferris J, Winstock AR, Lynskey MT, "Polysubstance use and misuse and abuse of prescription opioid analgesics: A multi-level analysis of international data," Pain, 158(6), 2017
Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L, "Why young people's substance use matters for global health," Lancet Psychiatry, 3(3), 2016
Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L, "Prevention, early intervention, harm reduction, and treatment of substance use in young people," Lancet Psychiatry, 3(3), 2016
Morley KI, Lynskey MT, Moran P, Borschmann R, Winstock A, "Polysubstance use, mental health, and high-risk behaviour: Results from the 2012 Global Drug Survey," Drug and Alcohol Review, 34(4), 2015
Morley KI, Wallace J, Denaxas SC, Hunter RJ, Patel R, Perel P, Shah AD, Timmis AD, Schilling RJ, Hemingway H., "Defining disease phenotypes using national linked electronic health records: A case study of atrial fibrillation," PLOS One, 9(11), 2014
Foley DL and Morley KI, "A systematic review of early cardiometabolic outcomes of the first treated episode of psychosis," Archives of General Psychiatry, 68(6), 2011